ACS Publications. Most Trusted. Most Cited. Most Read

OR SEARCH CITATIONS

My Activity
Publications
CONTENT TYPES

Figure 1Loading Img
Download Hi-Res ImageDownload to MS-PowerPointCite This:Biochemistry 2009, 48, 49, 11773-11785
RETURN TO ISSUEPREVArticleNEXT

Molecular Basis of Association of Receptor Activity-Modifying Protein 3 with the Family B G Protein-Coupled Secretin Receptor

View Author Information
‡ Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Scottsdale, Arizona 85259
# Drug Discovery Biology Laboratory, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Melbourne 3800, Australia
*Address for all the correspondence to Laurence J. Miller, MD, Mayo Clinic, 13400 East Shea Blvd, Scottsdale, AZ 85259. Tel.: (480) 301-6650. Fax: (480) 301-6969. E-mail: [email protected]
Cite this: Biochemistry 2009, 48, 49, 11773–11785
Publication Date (Web):November 3, 2009
https://doi.org/10.1021/bi901326k
Copyright © 2009 American Chemical Society
Request reuse permissions

    Article Views

    815

    Altmetric

    -

    Citations

    39
    LEARN ABOUT THESE METRICS
    Read OnlinePDF (3 MB)
    Get e-Alerts
    Supporting Info (1)»
    SUBJECTS:

    Abstract

    Abstract Image

    The three receptor activity-modifying proteins (RAMPs) have been recognized as being important for the trafficking and function of a subset of family B G protein-coupled receptors, although the structural basis for this has not been well established. In the current work, we use morphological fluorescence techniques, bioluminescence resonance energy transfer, and bimolecular fluorescence complementation to demonstrate that the secretin receptor associates specifically with RAMP3, but not with RAMP1 or RAMP2. We use truncation constructs, peptide competition experiments, and chimeric secretin−GLP1 receptor constructs to establish that this association is structurally specific, dependent on the intramembranous region of the RAMP and TM6 and TM7 of this receptor. There were no observed changes in secretin-stimulated cAMP, intracellular calcium, ERK1/2 phosphorylation, or receptor internalization in receptor-bearing COS or CHO-K1 cells in the presence or absence of exogenous RAMP transfection, although the secretin receptor trafficks normally to the cell surface in these cells in a RAMP-independent manner, resulting in both free and RAMP-associated receptor on the cell surface. RAMP3 association with this receptor was shown to be capable of rescuing a receptor mutant (G241C) that is normally trapped intracellularly in the biosynthetic machinery. Similarly, secretin receptor expression had functional effects on adrenomedullin activity, with increasing secretin receptor expression competing for RAMP3 association with the calcitonin receptor-like receptor to yield a functional adrenomedullin receptor. These data provide important new insights into the structural basis for RAMP3 interaction with a family B G protein-coupled receptor, potentially providing a highly selective target for drug action. This may be representative of similar interactions between other members of this receptor family and RAMP proteins.

    Supporting Information

    ARTICLE SECTIONS
    Jump To

    Supplemental data are available that show the alignment of the sequences of the human secretin and GLP1 receptors that was utilized to determine the sequences of the chimeric receptor constructs used in the current report. This material is available free of charge via the Internet at http://pubs.acs.org

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    This article is cited by 39 publications.

    1. Brian P Cary, Xin Zhang, Jianjun Cao, Rachel M Johnson, Sarah J Piper, Elliot J Gerrard, Denise Wootten, Patrick M Sexton. New Insights into the Structure and Function of Class B1 GPCRs. Endocrine Reviews 2023, 44 (3) , 492-517. https://doi.org/10.1210/endrev/bnac033
    2. Ilana B. Kotliar, Emily Lorenzen, Jochen M. Schwenk, Debbie L. Hay, Thomas P. Sakmar, . Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins. Pharmacological Reviews 2023, 75 (1) , 1-34. https://doi.org/10.1124/pharmrev.120.000180
    3. Irene Fasciani, Marco Carli, Francesco Petragnano, Francesco Colaianni, Gabriella Aloisi, Roberto Maggio, Marco Scarselli, Mario Rossi. GPCRs in Intracellular Compartments: New Targets for Drug Discovery. Biomolecules 2022, 12 (10) , 1343. https://doi.org/10.3390/biom12101343
    4. Lijun Shao, Yan Chen, Shikai Zhang, Zhihui Zhang, Yongbing Cao, Dehua Yang, Ming-Wei Wang. Modulating effects of RAMPs on signaling profiles of the glucagon receptor family. Acta Pharmaceutica Sinica B 2022, 12 (2) , 637-650. https://doi.org/10.1016/j.apsb.2021.07.028
    5. Maoqing Dong, Giuseppe Deganutti, Sarah J. Piper, Yi-Lynn Liang, Maryam Khoshouei, Matthew J. Belousoff, Kaleeckal G. Harikumar, Christopher A. Reynolds, Alisa Glukhova, Sebastian G. B. Furness, Arthur Christopoulos, Radostin Danev, Denise Wootten, Patrick M. Sexton, Laurence J. Miller. Structure and dynamics of the active Gs-coupled human secretin receptor. Nature Communications 2020, 11 (1) https://doi.org/10.1038/s41467-020-17791-4
    6. Ya-Xiong Tao. Molecular chaperones and G protein-coupled receptor maturation and pharmacology. Molecular and Cellular Endocrinology 2020, 511 , 110862. https://doi.org/10.1016/j.mce.2020.110862
    7. D. Stephen Serafin, Natalie R. Harris, Natalie R. Nielsen, Duncan I. Mackie, Kathleen M. Caron. Dawn of a New RAMPage. Trends in Pharmacological Sciences 2020, 41 (4) , 249-265. https://doi.org/10.1016/j.tips.2020.01.009
    8. Augen A. Pioszak, Debbie L. Hay. RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors. 2020, 115-141. https://doi.org/10.1016/bs.apha.2020.01.001
    9. Emily Lorenzen, Tea Dodig-Crnković, Ilana B. Kotliar, Elisa Pin, Emilie Ceraudo, Roger D. Vaughan, Mathias Uhlèn, Thomas Huber, Jochen M. Schwenk, Thomas P. Sakmar. Multiplexed analysis of the secretin-like GPCR-RAMP interactome. Science Advances 2019, 5 (9) https://doi.org/10.1126/sciadv.aaw2778
    10. Emma Dal Maso, Yue Zhu, Vi Pham, Christopher A. Reynolds, Giuseppe Deganutti, Caroline A. Hick, Dehua Yang, Arthur Christopoulos, Debbie L. Hay, Ming-Wei Wang, Patrick M. Sexton, Sebastian G.B. Furness, Denise Wootten. Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacy. Biochemical Pharmacology 2018, 150 , 214-244. https://doi.org/10.1016/j.bcp.2018.02.005
    11. Shahar Barbash, Emily Lorenzen, Torbjörn Persson, Thomas Huber, Thomas P. Sakmar. GPCRs globally coevolved with receptor activity-modifying proteins, RAMPs. Proceedings of the National Academy of Sciences 2017, 114 (45) , 12015-12020. https://doi.org/10.1073/pnas.1713074114
    12. Sarah J. Routledge, Graham Ladds, David R. Poyner. The effects of RAMPs upon cell signalling. Molecular and Cellular Endocrinology 2017, 449 , 12-20. https://doi.org/10.1016/j.mce.2017.03.033
    13. Joseph J. Gingell, Christopher S. Walker, Debbie L. Hay. Class B GPCR: Receptors and RAMPs. 2017, 289-305. https://doi.org/10.1007/978-3-319-60174-8_11
    14. Nadav Topaz, Nazia Mojib, Aroon T. Chande, Julia Kubanek, I. King Jordan. RampDB: a web application and database for the exploration and prediction of receptor activity modifying protein interactions. Database 2017, 2017 https://doi.org/10.1093/database/bax067
    15. Joseph J Gingell, John Simms, James Barwell, David R Poyner, Harriet A Watkins, Augen A Pioszak, Patrick M Sexton, Debbie L Hay. An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology. Cell Discovery 2016, 2 (1) https://doi.org/10.1038/celldisc.2016.12
    16. Cathryn Weston, Ian Winfield, Matthew Harris, Rose Hodgson, Archna Shah, Simon J. Dowell, Juan Carlos Mobarec, David A. Woodlock, Christopher A. Reynolds, David R. Poyner, Harriet A. Watkins, Graham Ladds. Receptor Activity-modifying Protein-directed G Protein Signaling Specificity for the Calcitonin Gene-related Peptide Family of Receptors. Journal of Biological Chemistry 2016, 291 (42) , 21925-21944. https://doi.org/10.1074/jbc.M116.751362
    17. Harriet A. Watkins, Madhuri Chakravarthy, Rekhati S. Abhayawardana, Joseph J. Gingell, Michael Garelja, Meenakshi Pardamwar, James M.W.R. McElhinney, Alex Lathbridge, Arran Constantine, Paul W.R. Harris, Tsz-Ying Yuen, Margaret A. Brimble, James Barwell, David R. Poyner, Michael J. Woolley, Alex C. Conner, Augen A. Pioszak, Christopher A. Reynolds, Debbie L. Hay. Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties. Journal of Biological Chemistry 2016, 291 (22) , 11657-11675. https://doi.org/10.1074/jbc.M115.688218
    18. Debbie L. Hay, Christopher S. Walker, Joseph J. Gingell, Graham Ladds, Christopher A. Reynolds, David R. Poyner. Receptor activity-modifying proteins; multifunctional G protein-coupled receptor accessory proteins. Biochemical Society Transactions 2016, 44 (2) , 568-573. https://doi.org/10.1042/BST20150237
    19. David Bell, Malcolm Campbell, Stephen F. McAleer, Matthew Ferguson, Liz Donaghy, Mark T. Harbinson. Endothelium-derived intermedin/adrenomedullin-2 protects human ventricular cardiomyocytes from ischaemia-reoxygenation injury predominantly via the AM 1 receptor. Peptides 2016, 76 , 1-13. https://doi.org/10.1016/j.peptides.2015.12.005
    20. Debbie L. Hay, Augen A. Pioszak. Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles. Annual Review of Pharmacology and Toxicology 2016, 56 (1) , 469-487. https://doi.org/10.1146/annurev-pharmtox-010715-103120
    21. Debbie L. Hay, Steve Chen, Thomas A. Lutz, David G. Parkes, Jonathan D. Roth, . Amylin: Pharmacology, Physiology, and Clinical Potential. Pharmacological Reviews 2015, 67 (3) , 564-600. https://doi.org/10.1124/pr.115.010629
    22. Ya-Xiong Tao, P. Michael Conn. Chaperoning G Protein-Coupled Receptors: From Cell Biology to Therapeutics. Endocrine Reviews 2014, 35 (4) , 602-647. https://doi.org/10.1210/er.2013-1121
    23. Aditya J. Desai, David J. Roberts, Gareth O. Richards, Timothy M. Skerry, . Role of Receptor Activity Modifying Protein 1 in Function of the Calcium Sensing Receptor in the Human TT Thyroid Carcinoma Cell Line. PLoS ONE 2014, 9 (1) , e85237. https://doi.org/10.1371/journal.pone.0085237
    24. Brian J. Arey. An Historical Introduction to Biased Signaling. 2014, 1-39. https://doi.org/10.1016/B978-0-12-411460-9.00001-X
    25. Guillermo G. Romero. The Role of the Cell Background in Biased Signaling. 2014, 41-79. https://doi.org/10.1016/B978-0-12-411460-9.00002-1
    26. Shabana Vohra, Bruck Taddese, Alex C. Conner, David R. Poyner, Debbie L. Hay, James Barwell, Philip J. Reeves, Graham J. G. Upton, Christopher A. Reynolds. Similarity between class A and class B G-protein-coupled receptors exemplified through calcitonin gene-related peptide receptor modelling and mutagenesis studies. Journal of The Royal Society Interface 2013, 10 (79) , 20120846. https://doi.org/10.1098/rsif.2012.0846
    27. Laurence J Miller, Maoqing Dong, Kaleeckal G Harikumar. Ligand binding and activation of the secretin receptor, a prototypic family B G protein‐coupled receptor. British Journal of Pharmacology 2012, 166 (1) , 18-26. https://doi.org/10.1111/j.1476-5381.2011.01463.x
    28. James Barwell, Joseph J Gingell, Harriet A Watkins, Julia K Archbold, David R Poyner, Debbie L Hay. Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?. British Journal of Pharmacology 2012, 166 (1) , 51-65. https://doi.org/10.1111/j.1476-5381.2011.01525.x
    29. James Barwell, Michael J. Woolley, Mark Wheatley, Alex C. Conner, David R. Poyner. The role of the extracellular loops of the CGRP receptor, a family B GPCR. Biochemical Society Transactions 2012, 40 (2) , 433-437. https://doi.org/10.1042/BST20110726
    30. David Bell, Malcolm Campbell, Matthew Ferguson, Leah Sayers, Liz Donaghy, Anna O’Regan, Victoria Jewhurst, Mark Harbinson. AM 1 ‐receptor‐dependent protection by intermedin of human vascular and cardiac non‐vascular cells from ischaemia–reperfusion injury. The Journal of Physiology 2012, 590 (5) , 1181-1197. https://doi.org/10.1113/jphysiol.2011.221895
    31. Cordelia J. Barrick, Patricia M. Lenhart, Ryan T. Dackor, Elizabeth Nagle, Kathleen M. Caron. Loss of receptor activity-modifying protein 3 exacerbates cardiac hypertrophy and transition to heart failure in a sex-dependent manner. Journal of Molecular and Cellular Cardiology 2012, 52 (1) , 165-174. https://doi.org/10.1016/j.yjmcc.2011.10.021
    32. Narayanan Parameswaran, William S. Spielman. Introduction to Ramps. 2012, 1-11. https://doi.org/10.1007/978-1-4614-2364-5_1
    33. James Barwell, Alex Conner, David R. Poyner. Extracellular loops 1 and 3 and their associated transmembrane regions of the calcitonin receptor-like receptor are needed for CGRP receptor function. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2011, 1813 (10) , 1906-1916. https://doi.org/10.1016/j.bbamcr.2011.06.005
    34. Julia K. Archbold, Jack U. Flanagan, Harriet A. Watkins, Joseph J. Gingell, Debbie L. Hay. Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development. Trends in Pharmacological Sciences 2011, 32 (10) , 591-600. https://doi.org/10.1016/j.tips.2011.05.007
    35. Mahita Kadmiel, Kimberly Fritz-Six, Suruchi Pacharne, Gareth O. Richards, Manyu Li, Tim M. Skerry, Kathleen M. Caron. Research Resource: Haploinsufficiency of Receptor Activity-Modifying Protein-2 (Ramp2) Causes Reduced Fertility, Hyperprolactinemia, Skeletal Abnormalities, and Endocrine Dysfunction in Mice. Molecular Endocrinology 2011, 25 (7) , 1244-1253. https://doi.org/10.1210/me.2010-0400
    36. Vera Brekhman, Jennie Lugassie, Shelly Zaffryar‐Eilot, Edmond Sabo, Ofra Kessler, Victoria Smith, Hana Golding, Gera Neufeld. Receptor activity modifying protein‐3 mediates the protumorigenic activity of lysyl oxidase‐like protein‐2. The FASEB Journal 2011, 25 (1) , 55-65. https://doi.org/10.1096/fj.10-162677
    37. John A Williams. Regulation of acinar cell function in the pancreas. Current Opinion in Gastroenterology 2010, 26 (5) , 478-483. https://doi.org/10.1097/MOG.0b013e32833d11c6
    38. Quan Chen, Laurence J. Miller, Maoqing Dong. Role of N -linked glycosylation in biosynthesis, trafficking, and function of the human glucagon-like peptide 1 receptor. American Journal of Physiology-Endocrinology and Metabolism 2010, 299 (1) , E62-E68. https://doi.org/10.1152/ajpendo.00067.2010
    39. Denise L. Wootten, John Simms, Debbie L. Hay, Arthur Christopoulos, Patrick M. Sexton. Receptor Activity Modifying Proteins and Their Potential as Drug Targets. 2010, 53-79. https://doi.org/10.1016/S1877-1173(10)91003-X
    Download PDF

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    MENDELEY PAIRING EXPIRED
    Your Mendeley pairing has expired. Please reconnect